| Dr Fairen Walker-mccarter, MD | |
|
28490 2nd St, Daphne, AL 36526-7150 | |
| (850) 226-6801 | |
| (877) 413-5104 |
| Full Name | Dr Fairen Walker-mccarter |
|---|---|
| Gender | Female |
| Speciality | Pain Management |
| Experience | 11 Years |
| Location | 28490 2nd St, Daphne, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942543533 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Usa Health University Hospital | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dynamic Pain And Wellness Pllc | 8527364058 | 33 |
| Dynamic Pain And Wellness Pllc | 8527364058 | 33 |
News Archive
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
The Centers for Medicare & Medicaid Services has said 2012 will be the year that hospitals should start paying to treat infections contracted on their premises. Many investors have the issue pegged as a janitorial concern, and not necessarily the purview of high-tech gadgets.
Patients with acute coronary syndromes (ACS) who are at high risk for bleeding have significantly lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous coronary intervention (PCI) with a polymer-free biolimus-A (BA9) drug-coated stent than with those receiving a bare metal stent (BMS) in results from a sub-study of the LEADERS FREE trial reported for the first time in a late-breaker session at EuroPCR 2016.
Mechanical engineering associate professor Jiangtao Cheng and electrical and computer engineering assistant professor Wei Zhou have developed an ultrasensitive biosensing method that could dramatically shorten the amount of time required to verify the presence of the COVID-19 virus in a sample.
› Verified 6 days ago
| Entity Name | Dynamic Pain & Wellness Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285007989 PECOS PAC ID: 8527364058 Enrollment ID: O20181012001431 |
News Archive
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
The Centers for Medicare & Medicaid Services has said 2012 will be the year that hospitals should start paying to treat infections contracted on their premises. Many investors have the issue pegged as a janitorial concern, and not necessarily the purview of high-tech gadgets.
Patients with acute coronary syndromes (ACS) who are at high risk for bleeding have significantly lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous coronary intervention (PCI) with a polymer-free biolimus-A (BA9) drug-coated stent than with those receiving a bare metal stent (BMS) in results from a sub-study of the LEADERS FREE trial reported for the first time in a late-breaker session at EuroPCR 2016.
Mechanical engineering associate professor Jiangtao Cheng and electrical and computer engineering assistant professor Wei Zhou have developed an ultrasensitive biosensing method that could dramatically shorten the amount of time required to verify the presence of the COVID-19 virus in a sample.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fairen Walker-mccarter, MD 17416 Stillwood Lane, Fairhope, AL 36532 Ph: (205) 807-7658 | Dr Fairen Walker-mccarter, MD 28490 2nd St, Daphne, AL 36526-7150 Ph: (850) 226-6801 |
News Archive
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
The Centers for Medicare & Medicaid Services has said 2012 will be the year that hospitals should start paying to treat infections contracted on their premises. Many investors have the issue pegged as a janitorial concern, and not necessarily the purview of high-tech gadgets.
Patients with acute coronary syndromes (ACS) who are at high risk for bleeding have significantly lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous coronary intervention (PCI) with a polymer-free biolimus-A (BA9) drug-coated stent than with those receiving a bare metal stent (BMS) in results from a sub-study of the LEADERS FREE trial reported for the first time in a late-breaker session at EuroPCR 2016.
Mechanical engineering associate professor Jiangtao Cheng and electrical and computer engineering assistant professor Wei Zhou have developed an ultrasensitive biosensing method that could dramatically shorten the amount of time required to verify the presence of the COVID-19 virus in a sample.
› Verified 6 days ago
Dr. Jonathan Clay Rainer, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 27961 Us Highway 98 Ste 10, Daphne, AL 36526 Phone: 251-626-0732 Fax: 251-272-1983 | |
David James Thomason, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 27961 Us Highway 98 Ste 10, Daphne, AL 36526 Phone: 251-626-0732 Fax: 251-272-1983 | |
Michael John Kohrman, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 26211 Equity Dr, Suite A, Daphne, AL 36526 Phone: 251-626-0901 Fax: 251-626-0902 |